Amlodipine And Benazepril Hydrochloride
NDC Package 23155-924-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Amlodipine And Benazepril Hydrochloride is capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent. Marketed by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., this product is identified by NDC 23155-924 and is authorized under FDA application ANDA091431.

Identification & Billing

NDC Package Code
23155-924-01
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
23155-924
11-Digit Billing Format
23155092401
RxNorm Crosswalk
  • RxCUI: 898342 - amLODIPine besylate 10 MG / benazepril HCl 20 MG Oral Capsule
  • RxCUI: 898342 - amlodipine 10 MG / benazepril hydrochloride 20 MG Oral Capsule
  • RxCUI: 898342 - amlodipine (as amlodipine besylate) 10 MG / benazepril hydrochloride 20 MG Oral Capsule
  • RxCUI: 898342 - Amlodipine 10 MG / BZP hydrochloride 20 MG Oral Capsule
  • RxCUI: 898346 - amLODIPine besylate 10 MG / benazepril HCl 40 MG Oral Capsule

Clinical Specifications

Proprietary Name
Amlodipine And Benazepril Hydrochloride
Dosage Form
-
Usage Information
Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.

Regulatory & Marketing

Labeler Name
Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
FDA Application #
ANDA091431
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-23-2026
End Marketing Date
05-23-2026
Listing Expiration
05-23-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (23155-924). Click a package code to view its specific billing and regulatory data.

23155-924-05
500 CAPSULE in 1 BOTTLE
23155-924-10
1000 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 23155-924-01 identifies a specific commercial package of 100 capsule in 1 bottle of Amlodipine And Benazepril Hydrochloride, labeled by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. on May 23, 2026. The current certification is valid through May 23, 2026.

How is this Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 23155092401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
23155-924-01
11-Digit CMS (5-4-2)
23155-0924-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.